尿性可以预测严重的大动脉狭窄症的无症状存活率和术后结果
Jutta Bergler-Klein1, Ursula Klaar, Maria Heger
1Department of Cardiology and the Ludwig Boltzmann Institute of Cardiovascular Research, University of Vienna, Vienna, Austria.
Circulation
|May 1, 2004
概括
包括N终端BNP (NtBNP) 在内的尿素,在严重的大动脉狭窄 (AS) 中提供了关键的预后见解. 升高的NtBNP水平独立预测无症状生存和术后结果,有助于手术时间.
科学领域:
- 心脏病学 心脏病学
- 临床医学 临床医学
- 生物标志物 生物标志物
背景情况:
- 大动脉狭窄症 (AS) 患者中尿酸的预后意义尚未得到充分确立.
- 大动脉狭窄是一种重要的心血管疾病,需要准确的预后评估.
研究的目的:
- 为了研究 natriuretic的预后价值在患有严重的大动脉狭窄症的患者.
- 为了确定 natriuretic是否可以预测无症状生存和AS患者的术后结果.
主要方法:
- 在130名严重的AS患者中测量B型尿素 (BNP),N终端尿素 (NtBNP) 和N终端心房尿素 (NtANP).
- 对无症状生存和术后结果的后续评估.
- 多变量分析包括临床和心声回声学数据.
主要成果:
- 尿素水平与NYHA类和射出分数 (EF) 相相关,即使在无症状患者中也会升高.
- 无症状患者后来出现症状,与那些没有症状的患者相比,基线NtBNP水平显著更高.
- 升高的NtBNP (<80 pmol/L与>=80 pmol/L) 与明显较低的无症状存活率有关.
- 多变量分析发现NtBNP是患者结果的唯一独立预测因子.
结论:
- 尿素,特别是NtBNP,在严重的AS中提供了重要的预后信息,超出了传统的临床和心声学评估.
- 手术前的NtBNP水平独立预测无症状生存率和术后的结果,包括生存率,症状状态和左心室功能.
- 神经激素水平,特别是NtBNP,对于优化严重AS无症状患者手术介入时间至关重要.
相关概念视频
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...


